MARKET

PSNL

PSNL

Personalis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

25.28
-0.91
-3.47%
After Hours: 25.40 +0.12 +0.47% 19:59 11/24 EST
OPEN
27.11
PREV CLOSE
26.19
HIGH
27.37
LOW
24.99
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
32.80
52 WEEK LOW
4.270
MARKET CAP
984.22M
P/E (TTM)
-23.7304
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event Nov. 18-19
MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for population sequencing and cancer, today announced that the company will participate in the EACR Liquid Biopsies
Benzinga · 6d ago
Personalis® to Present at the AMP Annual Meeting 2020
Personalis® to Present at the AMP Annual Meeting 2020
Business Wire · 11/16 14:00
Morgan Stanley Maintains Overweight on Personalis, Raises Price Target to $27
Morgan Stanley maintains Personalis (NASDAQ:PSNL) with a Overweight and raises the price target from $25 to $27.
Benzinga · 11/09 13:43
Benzinga's Top Upgrades, Downgrades For November 6, 2020
Upgrades * Needham upgraded the previous rating for Appian Corp (NASDAQ: APPN) from Hold to Buy. Appian earned $0.00 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Appian shows a 52-week-high of 84.81 and a 52-week-low of 29.07. Moreover, at the end of the last trading period, the closing price was at $75.22. * According to RBC Capital, the prior rating for Zillow Group Inc (NASDAQ: ZG) was changed from Sector Perform to Outperform. Zillow Gr earned $0.37 in the third quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of 112.2074 and a 52-week-low of 18.65. Zillow Gr closed at $104.11 at the end of the last trading period. * For Niu Technologies (NASDAQ: NIU), Citigroup upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Niu Technologies showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The current stock performance of Niu Technologies shows a 52-week-high of 34.02 and a 52-week-low of 6.08. Moreover, at the end of the last trading period, the closing price was at $31.74. * For Farfetch Ltd (NYSE: FTCH), Wells Fargo upgraded the previous rating of Underweight to the current rating Equal-Weight. In the second quarter, Farfetch showed an EPS of $0.20, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of 38.03 and a 52-week-low of 5.99. At the end of the last trading period, Farfetch closed at $37.80. * For EOG Resources Inc (NYSE: EOG), B of A Securities upgraded the previous rating of Neutral to the current rating Buy. For the third quarter, EOG Resources had an EPS of $0.43, compared to year-ago quarter EPS of $1.13. The current stock performance of EOG Resources shows a 52-week-high of 89.54 and a 52-week-low of 27.0001. Moreover, at the end of the last trading period, the closing price was at $35.59. * Benchmark upgraded the previous rating for Cooper-Standard Holdings Inc (NYSE: CPS) from Hold to Buy. Cooper-Standard Holdings earned $0.21 in the third quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of 39.32 and a 52-week-low of 6.64. Cooper-Standard Holdings closed at $20.00 at the end of the last trading period. * According to RBC Capital, the prior rating for Yelp Inc (NYSE: YELP) was changed from Sector Perform to Outperform. In the third quarter, Yelp showed an EPS of $0.01, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of 37.49 and a 52-week-low of 12.885. At the end of the last trading period, Yelp closed at $22.01. * For Ternium SA (NYSE: TX), JP Morgan upgraded the previous rating of Neutral to the current rating Overweight. Ternium earned $0.74 in the third quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of 23.6472 and a 52-week-low of 9.59. At the end of the last trading period, Ternium closed at $21.19. * According to RBC Capital, the prior rating for Olin Corp (NYSE: OLN) was changed from Underperform to Sector Perform. In the third quarter, Olin showed an EPS of $0.23, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of 20.4 and a 52-week-low of 8.76. At the end of the last trading period, Olin closed at $20.26. * According to Wells Fargo, the prior rating for Advanced Micro Devices Inc (NASDAQ: AMD) was changed from Equal-Weight to Overweight. Advanced Micro Devices earned $0.41 in the third quarter, compared to $0.18 in the year-ago quarter. The current stock performance of Advanced Micro Devices shows a 52-week-high of 94.28 and a 52-week-low of 35.52. Moreover, at the end of the last trading period, the closing price was at $83.00. Downgrades * For SAP SE (NYSE: SAP), Citigroup downgraded the previous rating of Buy to the current rating Neutral. For the third quarter, SAP had an EPS of $1.99, compared to year-ago quarter EPS of $1.42. At the moment, the stock has a 52-week-high of 169.3 and a 52-week-low of 90.895. SAP closed at $115.70 at the end of the last trading period. * JP Morgan downgraded the previous rating for New Relic Inc (NYSE: NEWR) from Neutral to Underweight. In the second quarter, New Relic showed an EPS of $0.07, compared to $0.24 from the year-ago quarter. The stock has a 52-week-high of 74.2 and a 52-week-low of 33.49. At the end of the last trading period, New Relic closed at $65.13. * According to Citigroup, the prior rating for Microchip Technology Inc (NASDAQ: MCHP) was changed from Buy to Neutral. In the second quarter, Microchip Technology showed an EPS of $1.56, compared to $1.43 from the year-ago quarter. The stock has a 52-week-high of 118.63 and a 52-week-low of 53.15. At the end of the last trading period, Microchip Technology closed at $118.38. * For FedNat Holding Co (NASDAQ: FNHC), Raymond James downgraded the previous rating of Outperform to the current rating Market Perform. FedNat Holding earned $1.57 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of 16.87 and a 52-week-low of 4.9001. At the end of the last trading period, FedNat Holding closed at $5.09. * According to Piper Sandler, the prior rating for Electronic Arts Inc (NASDAQ: EA) was changed from Overweight to Neutral. Electronic Arts earned $0.05 in the second quarter, compared to $0.97 in the year-ago quarter. The stock has a 52-week-high of 147.36 and a 52-week-low of 85.69. At the end of the last trading period, Electronic Arts closed at $128.33. * For Diodes Inc (NASDAQ: DIOD), Wells Fargo downgraded the previous rating of Overweight to the current rating Equal-Weight. For the second quarter, Diodes had an EPS of $0.54, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of 64.37 and a 52-week-low of 31.512. Diodes closed at $63.02 at the end of the last trading period. * Jefferies downgraded the previous rating for Vulcan Materials Co (NYSE: VMC) from Buy to Hold. Vulcan Materials earned $1.56 in the third quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of 153.88 and a 52-week-low of 65.56. Vulcan Materials closed at $137.38 at the end of the last trading period. * According to Goldman Sachs, the prior rating for Univar Solutions Inc (NYSE: UNVR) was changed from Buy to Neutral. In the third quarter, Univar Solns showed an EPS of $0.34, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of 24.77 and a 52-week-low of 6.4. Univar Solns closed at $17.67 at the end of the last trading period. * According to Oppenheimer, the prior rating for Personalis Inc (NASDAQ: PSNL) was changed from Outperform to Perform. For the third quarter, Personalis had an EPS of $0.27, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of 30.95 and a 52-week-low of 4.27. Personalis closed at $26.77 at the end of the last trading period. * According to JP Morgan, the prior rating for Pluralsight Inc (NASDAQ: PS) was changed from Overweight to Neutral. For the third quarter, Pluralsight had an EPS of $0.00, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of 22.69 and a 52-week-low of 6.59. At the end of the last trading period, Pluralsight closed at $19.00. * According to Jefferies, the prior rating for Martin Marietta Materials Inc (NYSE: MLM) was changed from Buy to Hold. Martin Marietta Materials earned $3.84 in the third quarter, compared to $3.96 in the year-ago quarter. At the moment, the stock has a 52-week-high of 281.82 and a 52-week-low of 135.08. Martin Marietta Materials closed at $260.07 at the end of the last trading period. * Credit Suisse downgraded the previous rating for Hudson Ltd (NYSE: HUD) from Outperform to Neutral. Hudson earned No EPS Value in the third quarter, compared to $0.26 in the year-ago quarter. The current stock performance of Hudson shows a 52-week-high of 15.87 and a 52-week-low of 2.26. Moreover, at the end of the last trading period, the closing price was at $7.65. * According to Raymond James, the prior rating for Global Blood Therapeutics Inc (NASDAQ: GBT) was changed from Outperform to Market Perform. For the third quarter, Global Blood Therapeutics had an EPS of $0.97, compared to year-ago quarter EPS of $1.07. The current stock performance of Global Blood Therapeutics shows a 52-week-high of 87.54 and a 52-week-low of 39.95. Moreover, at the end of the last trading period, the closing price was at $60.31. * Cantor Fitzgerald downgraded the previous rating for Benefitfocus Inc (NASDAQ: BNFT) from Overweight to Neutral. For the third quarter, Benefitfocus had an EPS of $0.08, compared to year-ago quarter EPS of $0.23. The current stock performance of Benefitfocus shows a 52-week-high of 25.505 and a 52-week-low of 6.09. Moreover, at the end of the last trading period, the closing price was at $10.90. * Piper Sandler downgraded the previous rating for BeiGene Ltd (NASDAQ: BGNE) from Neutral to Underweight. In the third quarter, BeiGene showed an EPS of $4.81, compared to $5.11 from the year-ago quarter. The current stock performance of BeiGene shows a 52-week-high of 322.98 and a 52-week-low of 118.55. Moreover, at the end of the last trading period, the closing price was at $300.00. * Jefferies downgraded the previous rating for Assembly Biosciences Inc (NASDAQ: ASMB) from Buy to Hold. For the third quarter, Assembly Biosciences had an EPS of $0.09, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of 27.84 and a 52-week-low of 10.23. At the end of the last trading period, Assembly Biosciences closed at $15.90. * For American Superconductor Corp (NASDAQ: AMSC), Canaccord Genuity downgraded the previous rating of Buy to the current rating Hold. For the second quarter, American Superconductor had an EPS of $0.13, compared to year-ago quarter EPS of $0.07. The current stock performance of American Superconductor shows a 52-week-high of 18.5 and a 52-week-low of 4.4. Moreover, at the end of the last trading period, the closing price was at $14.63.See more from Benzinga * Click here for options trades from Benzinga * Recap: OFS Capital Q3 Earnings * Entercom Communications: Q3 Earnings Insights(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 11/06 14:31
Personalis EPS beats by $0.01, beats on revenue
Personalis (PSNL): Q3 GAAP EPS of -$0.27 beats by $0.01.Revenue of $19.8M (+15.5% Y/Y) beats by $0.74M.Shares -4.2% AH.Press Release
Seekingalpha · 11/05 22:41
Personalis Q3 EPS $(0.27) Beats $(0.28) Estimate, Sales $19.80M Beat $19.06M Estimate
Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.28) by 3.57 percent. This is a 22.73 percent decrease over losses of $(0.22) per share from the
Benzinga · 11/05 21:11
Personalis Inc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 5, 2020 / Personalis Inc (NASDAQ:PSNL) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 5, 2020 at 5:00 PM Eastern Time.
ACCESSWIRE · 11/05 20:45
Analysts Estimate Personalis (PSNL) to Report a Decline in Earnings: What to Look Out for
Zacks · 10/29 17:35
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PSNL. Analyze the recent business situations of Personalis through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PSNL stock price target is 30.57 with a high estimate of 35.00 and a low estimate of 26.00.
EPS
Institutional Holdings
Institutions: 150
Institutional Holdings: 31.20M
% Owned: 80.13%
Shares Outstanding: 38.93M
TypeInstitutionsShares
Increased
36
7.06M
New
39
802.72K
Decreased
17
2.01M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.37%
Pharmaceuticals & Medical Research
0.00%
Key Executives
Chairman/Independent Director
Jonathan MacQuitty
President/Chief Executive Officer/Director
John West
Chief Financial Officer
Aaron Tachibana
Chief Scientific Officer
Richard Chen
General Counsel
Stephen Moore
Other
Clinton Musil
Independent Director
Patrick Balthrop
Independent Director
A. Blaine Bowman
Independent Director
Alan Colowick
Independent Director
Karin Eastham
Independent Director
Kenneth Ludlum
Independent Director
Paul Ricci
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About PSNL
Personalis, Inc. is a cancer genomics company. The Company is focused on the development of therapies by providing molecular data about each patient’s cancer and immune response. The Company has designed NeXT Platform, which provides its biopharmaceutical customers with information on over 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover over 50 to 500 genes. Its NeXT Platform is designed to provide analysis of both a tumor and its immune microenvironment from a single limited tissue sample. Its platform covers the deoxyribonucleic acid sequence of all of the approximately 20,000 human genes. It also report on the entire transcriptome of a tumor, which encompasses ribonucleic acid expression across human genes, allowing it to determine which of the genomic mutations might actually be driving tumor progression.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Personalis Inc stock information, including NASDAQ:PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.